Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series

Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...

Descripción completa

Detalles Bibliográficos
Autores principales: Konkol, Samuel B., Morrisette, Matthew J., Hulse, Matthew C., Enfield, Kyle B., Mihalek, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387627/
https://www.ncbi.nlm.nih.gov/pubmed/35799569
http://dx.doi.org/10.4103/aca.aca_98_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387627/
https://www.ncbi.nlm.nih.gov/pubmed/35799569
http://dx.doi.org/10.4103/aca.aca_98_21

Ejemplares similares